New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Duolingo Names Jim Shelton to Board of Directors
-
Illusive Networks Secures $24 Million in Latest Funding Round
-
Israeli cybersecurity firm Illusive raises $24 million in private round
-
UCB and Aetion Announce Agreement to Enhance Real-World Evidence Generation to Advance Value-Based Contracts
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform
-
Horizon Technology Finance Provides $15 Million Venture Loan Facility to Topia, a leader in Global Talent Mobility
-
Korro Bio Appoints Omar Khwaja, M.D., Ph.D. to its Board of Directors
-
D.C. Housing Authority Offers Woebot to Employees and Residents
-
Beyond Identity Taps Adam Clay as Chief Revenue Officer
-
Wall Street's IPO enemies ready one-two punch
-
Form SC 13D Metacrine, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Conviva Care Centers Teams with Strive Health to Provide Kidney Disease Care Management to Patients in South Florida
-
Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform
-
BioInnovation Institute partners with eight international VCs
-
Strive Health Welcomes David Thornton as Chief People Officer
-
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
-
CIT GAP Funds Makes Follow-On Investment in NOVI to Advance the Next Generation of Small-Satellites
-
Form SC 13D/A Mersana Therapeutics, Filed by: New Enterprise Associates 14, L.P.
-
Form 4 Mersana Therapeutics, For: Sep 14 Filed by: New Enterprise Associates 14, L.P.
-
H1 2020 financial results and corporate business update
-
H1 2020 financial results and corporate business update
-
DataRobot Named to Forbes’ List of Top 100 Private Cloud Companies in the World
-
Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million
-
Beyond Identity Joins ForgeRock’s Trust Network of Certified Technology Partners to Deliver Passwordless Single Sign-On and Risk-Based Authorization
-
Beyond Identity Joins ForgeRock’s Trust Network of Certified Technology Partners to Deliver Passwordless Single Sign-On and Risk-Based Authorization
-
Firms will invest more in AI after the pandemic, but delivering ROI will take skill, scale, and time
-
DataRobot Introduces Major Enhancements to Its Enterprise AI Platform
-
Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics
-
Topia Partners with BCD Travel to Automate Business Travel and Distributed Workforce Compliance
-
DataRobot Introduces More Intelligent Tomorrow Podcast
-
Xfund 3 Raises Oversubscribed Fund to Back University-Based Innovation
-
CIT’s Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics
-
Topia Achieves Record Growth Driven By its Tax Compliance Solutions for Newly Distributed Workforces
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
CIT Announces MACH37 Investment in Cervais for Improved Endpoint Security
-
GRID Raises $12M in Series A Funding led by NEA to Revolutionize Data Work
-
Aetion adds strategic investment from Johnson & Johnson Innovation - JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings
-
Form SC 13D Bloom Energy Corp Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Total Economic Impact Study Reveals 514% Return on Investment with DataRobot
-
Form 4 Bloom Energy Corp For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
DataRobot Appoints Parm Uppal as Chief Revenue Officer
-
Timescale Brings Powerful Time-Series Data Analysis to Developers Worldwide, Now Available in 75+ Cloud Regions
-
DataRobot Launches Pathfinder: A Comprehensive Library of 100+ AI Use Cases
-
Form 4 Cloudflare, Inc. For: Aug 07 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
AVEO Oncology Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Verona Pharma plc: TR-1: Standard form for notification of major holdings

